548 related articles for article (PubMed ID: 2973508)
1. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
3. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
Lala PK; Parhar RS
Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
[TBL] [Abstract][Full Text] [Related]
4. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: characteristics of killer cells generated in situ.
Lala PK; Elkashab M; Kerbel RS; Parhar RS
Int Immunol; 1990; 2(12):1149-58. PubMed ID: 2090199
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Khoo NK; Chan FP; Saarloos MN; Lala PK
Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
[TBL] [Abstract][Full Text] [Related]
7. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
9. Cure of murine Ehrlich ascites tumors with chronic oral indomethacin therapy combined with intraperitoneal administration of LAK cells and IL-2.
Lala PK; Parhar RS; Singh P; Lala PK
Cancer Lett; 1990 May; 51(1):27-35. PubMed ID: 2337895
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin-mediated inactivation of natural killer cells in the murine decidua.
Scodras JM; Parhar RS; Kennedy TG; Lala PK
Cell Immunol; 1990 May; 127(2):352-67. PubMed ID: 2139365
[TBL] [Abstract][Full Text] [Related]
12. PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity.
Parhar RS; Yagel S; Lala PK
Cell Immunol; 1989 Apr; 120(1):61-74. PubMed ID: 2784722
[TBL] [Abstract][Full Text] [Related]
13. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity.
Parhar RS; Lala PK
Cell Immunol; 1985 Jul; 93(2):265-79. PubMed ID: 3159480
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.
Leung KH
Cell Immunol; 1989 Oct; 123(2):384-95. PubMed ID: 2507171
[TBL] [Abstract][Full Text] [Related]
15. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise.
Lala PK; Scodras JM; Graham CH; Lysiak JJ; Parhar RS
Cell Immunol; 1990 May; 127(2):368-81. PubMed ID: 2328531
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.
Parhar RS; Lala PK
J Exp Med; 1987 Jan; 165(1):14-28. PubMed ID: 3491867
[TBL] [Abstract][Full Text] [Related]
17. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
Flexman JP; Manning LS; Robinson BW
Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-mediated suppression of murine lymphokine-activated killer cell activity generated from tumor-bearing hosts by interferon-gamma.
Nakajima I; Chu TM
Mol Biother; 1990 Dec; 2(4):228-32. PubMed ID: 2126942
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
Vujanovic NL; Herberman RB; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
Ting CC; Hargrove ME
J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
